AGP in medicine most commonly stands for Ambulatory Glucose Profile, a standardized one-page report that summarizes data from a continuous glucose monitor (CGM) over multiple days. It’s the international standard for visualizing blood sugar patterns in people with diabetes. The abbreviation can also refer to aerosol generating procedures in infection control or alpha-1-acid glycoprotein in blood chemistry, though the diabetes-related meaning is by far the most widely searched.
The Ambulatory Glucose Profile Explained
An AGP report takes anywhere from 5 days to 3 months of CGM readings and compresses them into a single 24-hour picture. Imagine layering every day’s glucose data on top of each other so you can see what your blood sugar typically does at 7 a.m., at noon, at 3 a.m., and every point in between. Instead of scrolling through hundreds of individual readings, you get one graph that reveals patterns: a consistent spike after breakfast, a dip in the late afternoon, or unstable overnight levels you might never have noticed otherwise.
The AGP was originally created by researchers led by Roger Mazze and later developed into its current form by the International Diabetes Center. In 2019, an international consensus conference endorsed it as the standard way to present CGM data, and the American Diabetes Association now references it in its annual Standards of Care.
What the AGP Report Contains
A standard AGP report has three sections packed onto a single page: glucose statistics and targets, the AGP graph itself, and daily glucose profiles showing each individual day.
The statistics section presents 10 key metrics. The most important ones for most people include:
- Time in Range (TIR): The percentage of time your glucose stays between 70 and 180 mg/dL. The goal for most adults is above 70%, which roughly corresponds to an A1C of about 7%.
- Time Below Range (TBR): Time spent under 70 mg/dL, which signals hypoglycemia. The target is less than 4% for most adults and less than 1% for older adults.
- Time Above Range (TAR): Time spent above 180 mg/dL. The goal is less than 25% in the mildly elevated zone (181 to 250 mg/dL) and less than 5% in the more concerning zone above 250 mg/dL.
- Glucose Management Indicator (GMI): An estimated A1C calculated from your CGM data, giving you a real-time proxy for the lab test.
- Coefficient of Variation (CV): A measure of how much your glucose swings throughout the day. Lower numbers mean more stable levels.
Reading the AGP Graph
The graph uses shaded bands and lines to show how variable your glucose is across a typical day. The solid center line is your median: half of all readings fall above it, half below. A dark shaded band around the median marks the interquartile range (the middle 50% of your readings). If this band is narrow, your glucose is fairly predictable at that time of day. If it’s wide, there’s a lot of day-to-day variation.
Dashed outer lines mark the 10th and 90th percentiles, meaning only 10% of readings ever went above the upper line or below the lower one. These outer boundaries help you spot outlier events, like rare but severe lows overnight, that the middle band might hide. A horizontal shaded zone on the graph marks the target range of 70 to 180 mg/dL so you can instantly see where your glucose curve falls outside of it.
Why AGP Matters More Than A1C Alone
A1C tells you your average blood sugar over roughly three months, but it says nothing about the journey. Two people can have an identical A1C of 7% while living very different realities: one stays steadily between 100 and 160 mg/dL, while the other swings between 50 and 300 mg/dL multiple times a day. The AGP report captures that difference. It shows the timing, severity, and consistency of highs and lows, which lets you and your care team make specific adjustments, like changing a meal bolus or shifting the timing of a long-acting insulin, rather than guessing based on a single number.
The daily glucose profiles section adds another layer by displaying each day individually. This helps identify whether an alarming spike was a one-off (a birthday dinner, a sensor error) or a repeating pattern that needs attention.
Other Medical Meanings of AGP
Aerosol Generating Procedures
In infection control, AGP refers to medical procedures that produce airborne particles at higher concentrations than normal breathing, coughing, or sneezing. This became a widely discussed term during the COVID-19 pandemic because these procedures put healthcare workers at greater risk of inhaling infectious aerosols. Common examples include endotracheal intubation, CPR, bronchoscopy, open airway suctioning, sputum induction, and noninvasive ventilation like CPAP or BiPAP. The CDC notes there is no universally agreed-upon definitive list, and some procedures (like nebulizer treatments and high-flow oxygen) remain in a gray area.
When performing AGPs on patients with suspected or confirmed respiratory infections, healthcare workers are expected to wear a fit-tested N95 respirator or higher, along with gloves, a gown, and face or eye protection. Standard surgical masks are not considered sufficient in these situations.
Alpha-1-Acid Glycoprotein
AGP can also refer to alpha-1-acid glycoprotein, a protein produced by the liver that circulates in the bloodstream. Its primary job is binding to and transporting various substances, including many medications. The protein’s levels rise during inflammation, infection, and certain liver diseases, making it a useful biomarker. From a practical standpoint, elevated AGP levels can affect how drugs are distributed in the body: when more AGP is present, it can bind more of a medication, potentially reducing the amount that’s free to work. This is mainly relevant in clinical pharmacology and is not something most patients encounter by name.